BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 25425683)

  • 21. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of abnormal clones by the fluorescent aerolysin method in paroxysmal nocturnal haemoglobinuria and other marrow disorders.
    Agarwal R; Chapple P; Brown M; Szer J; Juneja S
    Int J Lab Hematol; 2015 Feb; 37(1):14-21. PubMed ID: 24702736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The value of flow cytometry for the differential diagnosis between refractory cytopenia with multiple dysplasia and aplastic anemia].
    Xue LF; Yang B; Zhou J; Wang XQ; Lin GW
    Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):508-11. PubMed ID: 20979740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
    Varma N; Varma S; Marwaha N; Garewal G
    Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Cytokine-Based Diagnostic Program in Pediatric Aplastic Anemia and Hypocellular Refractory Cytopenia of Childhood.
    Elmahdi S; Hama A; Manabe A; Hasegawa D; Muramatsu H; Narita A; Nishio N; Ismael O; Kawashima N; Okuno Y; Xu Y; Wang X; Takahashi Y; Ito M; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):652-8. PubMed ID: 26485171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotypic features of granulocytes, monocytes, and blasts in myelodysplastic syndromes.
    Moon HW; Huh JW; Lee M; Hong KS; Chung WS
    Korean J Lab Med; 2010 Apr; 30(2):97-104. PubMed ID: 20445324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Survey on examinations for diagnosis of bone marrow failure in Japan: a report from the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes].
    Araseki K; Matsuda A; Tohyama K; Ishikawa T; Kawabata H; Miyazaki Y; Nakao S; Tomonaga M; Takaori-Kondo A; Kurokawa M; Omine M; Ozawa K
    Rinsho Ketsueki; 2012 Jul; 53(7):691-7. PubMed ID: 22975771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flow cytometry immunophenotyping for the evaluation of bone marrow dysplasia.
    Della Porta MG; Lanza F; Del Vecchio L;
    Cytometry B Clin Cytom; 2011; 80(4):201-11. PubMed ID: 21674774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic significance of immunophenotyping of bone marrow cells in myelodysplastic syndrome without an increase of marrow blasts].
    Xu J; Zhang W; Liu Y; Wan SG; Sun XJ; Zhao H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1477-81. PubMed ID: 20030930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of childhood aplastic anemia and myelodysplastic syndrome.
    Niemeyer CM; Baumann I
    Hematology Am Soc Hematol Educ Program; 2011; 2011():84-9. PubMed ID: 22160017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translating the MDS flow cytometric score into clinical practice.
    Heron M; Dovern E; Bakker-Jonges LE; Posthuma EF; Brouwer RE; Smedts F; Batstra MR
    Cytometry B Clin Cytom; 2015; 88(3):207-9. PubMed ID: 25490972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
    Barrett J; Saunthararajah Y; Molldrem J
    Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell receptor Vbeta CDR3 oligoclonality frequently occurs in childhood refractory cytopenia (MDS-RC) and severe aplastic anemia.
    de Vries AC; Langerak AW; Verhaaf B; Niemeyer CM; Stary J; Schmiegelow K; van Wering ER; Zwaan CM; Beishuizen A; Pieters R; van den Heuvel-Eibrink MM
    Leukemia; 2008 Jun; 22(6):1170-4. PubMed ID: 18323803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia.
    Iwafuchi H; Ito M
    Histopathology; 2019 Jan; 74(2):239-247. PubMed ID: 30062702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders.
    Lorand-Metze I; Ribeiro E; Lima CS; Batista LS; Metze K
    Leuk Res; 2007 Feb; 31(2):147-55. PubMed ID: 16750852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
    Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
    Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface marker abnormalities in myelodysplastic syndromes.
    Elghetany MT
    Haematologica; 1998 Dec; 83(12):1104-15. PubMed ID: 9949628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptotic cells and clonally expanded cytotoxic T cells in bone marrow trephines of patients with myelodysplastic syndrome.
    Pülhorn H; Herrmann M; Harms H; Jung A; Baumann I
    Histopathology; 2012 Aug; 61(2):200-11. PubMed ID: 22690734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of flow cytometric immunophenotyping in myelodysplastic syndromes.
    Pagnucco G; Giambanco C; Gervasi F
    Ann N Y Acad Sci; 2006 Nov; 1089():383-94. PubMed ID: 17261782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.